BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 15866584)

  • 21. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
    Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
    Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome.
    Gulcelik NE; Aral Y; Serter R; Demir Y; Culha C
    Gynecol Endocrinol; 2006 Sep; 22(9):511-5. PubMed ID: 17071536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance].
    Chu YL; Qiu HY; Sun YY; Li M; Li HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):455-8. PubMed ID: 17083810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased circulating soluble P-selectin in polycystic ovary syndrome.
    Yildiz BO; Bozdag G; Harmanci A; Otegen U; Boynukalin K; Vural Z; Kirazli S; Haznedaroglu IC; Yarali H
    Fertil Steril; 2010 May; 93(7):2311-5. PubMed ID: 19261277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
    Belli SH; Graffigna MN; Oneto A; Otero P; Schurman L; Levalle OA
    Fertil Steril; 2004 Mar; 81(3):624-9. PubMed ID: 15037412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.
    Celik O; Sahin I; Celik N; Hascalik S; Keskin L; Ozcan H; Uckan A; Kosar F
    Hum Reprod; 2007 Nov; 22(11):2992-8. PubMed ID: 17855407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis.
    Mor E; Zograbyan A; Saadat P; Bayrak A; Tourgeman DE; Zhang C; Stanczyk FZ; Paulson RJ
    Am J Obstet Gynecol; 2004 Jun; 190(6):1654-60. PubMed ID: 15284763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
    Uncu G; Ozyurek SE; Uncu Y
    Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vryonidou A; Ioannidis D; Kosma L; Katsoulis K; Papavassiliou E; Tzavara I
    Hum Reprod; 2010 Jan; 25(1):212-20. PubMed ID: 19887498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values.
    Kim JJ; Hwang KR; Oh SH; Chae SJ; Yoon SH; Choi YM
    Fertil Steril; 2019 Nov; 112(5):959-966.e1. PubMed ID: 31542165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.
    Sawathiparnich P; Weerakulwattana L; Santiprabhob J; Likitmaskul S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S33-7. PubMed ID: 16856423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.